Laman UtamaPLX • NYSEAMERICAN
add
Protalix Biotherapeutics Inc
Tutup sebelumnya
$1.79
Julat hari
$1.74 - $1.80
Julat tahun
$1.32 - $3.10
Permodalan pasaran
139.93J USD
Bilangan Purata
588.60K
Nisbah P/E
37.69
Hasil dividen
-
Berita pasaran
Stockhouse
1 hari lalu
the Bell: TSX Index slumps into Christmas holiday | 2025-12-24 | Investing News
0.18%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 17.85J | -0.60% |
Perbelanjaan pengendalian | 7.40J | 32.24% |
Pendapatan bersih | 2.36J | -27.22% |
Margin untung bersih | 13.19 | -26.80% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 2.50J | -42.06% |
Kadar cukai berkesan | -5.18% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 29.37J | 7.15% |
Jumlah aset | 82.26J | 33.63% |
Jumlah liabiliti | 29.36J | 0.79% |
Jumlah ekuiti | 52.91J | — |
Syer tertunggak | 80.42J | — |
Harga kepada buku | 2.70 | — |
Pulangan pada aset | 6.63% | — |
Pulangan pada modal | 9.16% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 2.36J | -27.22% |
Tunai daripada operasi | -3.73J | -190.91% |
Tunai daripada pelaburan | -504.00K | -102.48% |
Tunai daripada pembiayaan | 0.00 | 100.00% |
Perubahan bersih dalam tunai | -4.25J | -205.94% |
Aliran tunai bebas | -6.02J | -671.68% |
Perihal
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
CEO
Diasaskan
1993
Ibu pejabat
Tapak web
Pekerja
213
